12/24
04:17 pm
zts
Zoetis (NYSE:ZTS) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.
Low
Report
Zoetis (NYSE:ZTS) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.
12/20
04:46 am
zts
Veterinary Medicine Market Size to Hit USD 98.51 Billion by 2033, Growing at a CAGR of 8.11% - SNS Insider [Yahoo! Finance]
Low
Report
Veterinary Medicine Market Size to Hit USD 98.51 Billion by 2033, Growing at a CAGR of 8.11% - SNS Insider [Yahoo! Finance]
12/19
08:09 am
zts
Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. [Yahoo! Finance]
Low
Report
Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. [Yahoo! Finance]
12/18
10:58 am
zts
Zoetis (NYSE:ZTS) was given a new $160.00 price target on by analysts at Morgan Stanley.
Low
Report
Zoetis (NYSE:ZTS) was given a new $160.00 price target on by analysts at Morgan Stanley.
12/18
08:30 am
zts
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/16
01:34 am
zts
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering [Yahoo! Finance]
Low
Report
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering [Yahoo! Finance]
12/16
01:15 am
zts
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
Low
Report
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
12/15
10:17 am
zts
Zoetis (NYSE:ZTS) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $135.00 price target on the stock.
Low
Report
Zoetis (NYSE:ZTS) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $135.00 price target on the stock.
12/15
08:44 am
zts
Zoetis (NYSE:ZTS) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
Low
Report
Zoetis (NYSE:ZTS) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
12/15
07:21 am
zts
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering [Yahoo! Finance]
Low
Report
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering [Yahoo! Finance]
12/15
07:09 am
zts
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Medium
Report
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
12/12
11:25 pm
zts
HSBC Cuts Zoetis Inc. (ZTS)'s Price Target To $140 From $180, Keeps Buy Rating [Yahoo! Finance]
Low
Report
HSBC Cuts Zoetis Inc. (ZTS)'s Price Target To $140 From $180, Keeps Buy Rating [Yahoo! Finance]
12/11
04:15 pm
zts
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
Low
Report
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
12/10
08:04 am
zts
Zoetis (NYSE:ZTS) was given a new $140.00 price target on by analysts at HSBC Holdings plc.
Low
Report
Zoetis (NYSE:ZTS) was given a new $140.00 price target on by analysts at HSBC Holdings plc.
12/10
07:18 am
zts
Zoetis (NYSE:ZTS) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Zoetis (NYSE:ZTS) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/8
05:04 pm
zts
Zoetis (NYSE:ZTS) is now covered by analysts at Barclays PLC. They set a "neutral" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) is now covered by analysts at Barclays PLC. They set a "neutral" rating on the stock.
12/5
09:10 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
12/5
08:30 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
12/4
10:58 am
zts
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
12/3
08:06 am
zts
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
12/2
11:46 am
zts
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
Low
Report
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
12/2
07:30 am
zts
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
Low
Report
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
11/26
04:15 pm
zts
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Low
Report
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
11/20
05:05 pm
zts
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
Medium
Report
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
11/20
08:30 am
zts
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference